Answers are grounded in this paper and cite their sources.
In allogeneic blood and bone marrow transplantation (BMT), patients lacking an available HLA-matched sibling donor must resort to a related haploidentical donor or an unrelated individual who is HLA-matched or multiple antigen-mismatched. In these situations, the likely development of graft-versus-host disease (GVHD) can be avoided by T cell depletion of the donor inoculum. Unfortunately, T cell depletion is usually accompanied by an increased risk of leukemic relapse, engraftment failure, and severe prolonged immunodeficiency, thus eliminating any survival advantage [1].
No takes yet. Share an insight, caveat, or question.
Friedman et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: